Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Capone

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Clinical Drug Investigation|September 8, 2018
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in ItalyRaffaella Viti, Andrea Marcellusi, Alessandro Capone, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II StudyKatrin Haeussler, Andrea Marcellusi, Francesco Saverio Mennini, et al.
Medical Care|August 28, 2012
Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST studyGiampiero Favato, Gianluca Baio, Alessandro Capone, et al.
Medical Care|March 14, 2013
Transparency or proper study valuation procedures missed?Giampiero Favato, Gianluca Baio, Alessandro Capone, et al.
The New Microbiologica|June 11, 2016
Isolation of KPC 3-producing Enterobacter aerogenes in a patient colonized by MDR Klebsiella pneumoniaeCarolina Venditti, Laura Villa, Alessandro Capone, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009Riccardo Utili, Alberto Cogo, Francesco Cristini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 20, 2019
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factorsEmanuele Nicastri, Francesco Vairo, Paola Mencarini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 29, 2021
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniaeCarolina Venditti, Ornella Butera, Marcello Meledandri, et al.
Clinical Therapeutics|July 27, 2011
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in ItalyFrancesco Saverio Mennini, Donatella Panatto, Andrea Marcellusi, et al.
Antibiotics (Basel, Switzerland)|February 14, 2020
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant <i>Enterobacterales</i>Antonio Vena, Daniele Roberto Giacobbe, Nadia Castaldo, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Clinical Drug Investigation|September 8, 2018
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in ItalyRaffaella Viti, Andrea Marcellusi, Alessandro Capone, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II StudyKatrin Haeussler, Andrea Marcellusi, Francesco Saverio Mennini, et al.
Medical Care|August 28, 2012
Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST studyGiampiero Favato, Gianluca Baio, Alessandro Capone, et al.
Medical Care|March 14, 2013
Transparency or proper study valuation procedures missed?Giampiero Favato, Gianluca Baio, Alessandro Capone, et al.
The New Microbiologica|June 11, 2016
Isolation of KPC 3-producing Enterobacter aerogenes in a patient colonized by MDR Klebsiella pneumoniaeCarolina Venditti, Laura Villa, Alessandro Capone, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009Riccardo Utili, Alberto Cogo, Francesco Cristini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 20, 2019
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factorsEmanuele Nicastri, Francesco Vairo, Paola Mencarini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 29, 2021
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniaeCarolina Venditti, Ornella Butera, Marcello Meledandri, et al.
Clinical Therapeutics|July 27, 2011
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in ItalyFrancesco Saverio Mennini, Donatella Panatto, Andrea Marcellusi, et al.
Antibiotics (Basel, Switzerland)|February 14, 2020
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant <i>Enterobacterales</i>Antonio Vena, Daniele Roberto Giacobbe, Nadia Castaldo, et al.
Pageof 7